JohnSampsonMDPhD, MBA

PubMed

• 807 citations
  Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
  David A. Reardon, Alba A. Brandes, Antonio Omuro, Paul Mulholland, Michael Lim
  JAMA Oncology. 2020-07-01
• 406 citations
  Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.
  Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, Franziska Loebel, Xiuyu Cui
  Nature Medicine. 2018-08-13
• 494 citations
  Challenges to curing primary brain tumours
  Kenneth Aldape, Kevin M. Brindle, Louis Chesler, Rajesh Chopra, Amar Gajjar
  Nature Reviews. Clinical Oncology. 2019-02-07

Journal Articles

• Sequestration of T Cells in Bone Marrow in the Setting of Glioblastoma and Other Intracranial Tumors  
  Peter E Fecci, Cosette A Dechant, Robert L Martuza, Karolina Woroniecka, Brian V Nahed, James E Herndon, William T Curry, Aladine A Elsamadicy, John H Sampson, Michael..., Nature
• Complete response to steroids in dural inflammatory pseudotumor associated with Still's disease  
  Batich, K.B., St. Clair, E.W., McLendon, R.E., Sampson, J.H., J Clin Neurosci, 10/1/2013
• Isocitrate dehydrogenase 1 (IDH1): What it means to the neurosurgeon  
  Hodges, T.R., Choi, B.D., Bigner, D.D., Yan, H., Sampson, J.H., J Neurosurg, 6/1/2013
• Clinicopathological Characteristics and Treatment of Rhabdoid Glioblastoma  
  Babu, R., Hatef, J., McLendon, R., Cummings, T., Sampson, J.H., Friedman, A.H., Adamson, C., J Neurosurg, 5/3/2013
• A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous system  
  Choi, B.D., Pastan, I., Bigner, D.D., Sampson, J.H., Oncoimmunology, 4/1/2013
• Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade  
  Nonaka, Y., Fukushima, T., Watanabe, K., Friedman, A.H., Sampson, J.H., McElveen, J.T. Jr., Cunningham, C.D. 3rd, Zomorodi, A.R., Neurosurgery, 1/1/2013
• Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma  
  Choi, B.D., Kuan, C.T., Cai, M., Archer, G.E., Mitchell, D.A., Gedeon, P.C., Sanchez-Perez, L, Pastan, I., Bigner, D.D., Sampson, J.H., Proc. Natl. Acad. Sci. U.S.A., 1/1/2013
• Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier  
  Mehta, A.I, Brufsky, A.M., Sampson, J.H., Cancer Treat Rev, 1/1/2013
• Thickness of subcutaneous fat as a risk factor for infection in cervical spine fusion surgery  
  Mehta, A.I., Babu, R., Sharma, R., Karikari, I.O., Grunch, B.H., Owens, T.R., Agarwal, V.J., Sampson, J.H., Lad, S.P., Friedman, A.H., Kuchibhatla, M., Bagley, C.A., G..., J Bone Join Surg Am, 1/1/2013
• BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide  
  Sanchez-Perez, L., Choi, B., Reap, E., Sayour, E., Norberg, P., Schmittling, R., Archer, G., Herndon, II J., Mitchell, D.A., Heimberger, A., Bigner, D., Sampson, J.H., Canc Immunol Immunother, 1/1/2013
• Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial  
  Cabrera, A.R., Cuneo, K.C., Desjardins, A., Sampson, J.H., McSherry, F., Herndon, JE., II, Peters, K.B., Allen, K.J., Hoang, J.K., Chang, Z., Craciunescu, O., Vredenbu..., Int J Radiat Oncol Biol Phys, 1/1/2013
• An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma  
  Reardon, D.A., Wucherpfennig, K.W., Freeman, G., Wu, C.J., Chiocca, E.A., Wen, P.Y., Curry, W.T., Jr., Mitchell, D.A., Fecci, P.E., Sampson, J.H., Dranoff, G., Expert Rev Vaccines, 1/1/2013
• Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis  
  Choi, B.D., Gedeon, P.C., Kuan, C.T., Bigner, D.D., Sampson, J.H., J Immunol Methods, 1/1/2013
• 107 Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma  
  Sampson, J.H., Desijardins, A., Peters, K.B., Ranjan, T., Vlahovic, G., Lally-Goss, D., Threatt, S., Herndon, J., Friedman, A.H., Friedman, H., Bigner, D., Gromeier, M, Neurosurgery, 1/1/2013
• Rindopepimut  
  Gedeon, P.C., Choi, B.D., Sampson, J.H., Bigner, D.D., Drugs Future, 1/1/2013
• Radiotherapy and radiosurgery for tumors of the central nervous system  
  Kirkpatrick, J.P., Yin, F.F., Sampson, J.H., Surg Oncol Clin N Am, 1/1/2013
• Melanoma immunotherapy using mature DCs expressing the constitutive proteasome  
  Dannull, J., Haley, N.R., Archer, G.E., Nair, S., Boczkowski, D., Harper, M., De Rosa, N., Pickett, N., Mosca, P.J., Burchette, J., Selim, M.A., Mitchell, D.A., Sampso..., J Clin Invest, 1/1/2013
• An EGFRvIII-targeted bispecific antibody overcomes limitations of the current standard of care for glioblastoma by inducing tumor cell specific cytotoxicity  
  Gedeon, P.C., Choi, B.D., Hodges, T.R., Mitchell, D.A., Bigner, D.D., Sampson, J.H., Expert Rev Clin Pharmacol, 1/1/2013
• A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model  
  Yang, S., Archer, G.E., Flores, C.E., Mitchell, D.A., Sampson, J.H., Cancer Immunol Immunother, 1/1/2013
• Immunotherapy with tumor vaccines for the treatment of malignant gliomas  
  Ajay, D., Sanchez-Perez, L, Choi, B.D., De Leon, G., Sampson, J.H., Curr Drug Discov Technol, 12/1/2012
• Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas  
  Cuneo, K.C., Vredenburgh, J.J., Sampson, J.H., Reardon, D.A., Desjardins, A., Peters, K.L., Willett, C.G., Kirkpatrick, J.P., Int. J. Radiat. Oncol. Biol. Phys., 4/1/2012
• Editorial: Disparities in Care  
  Sampson, J.H., Bagley, C.A., Carson, B.S., J Neurosurg, 2/1/2012
• Phase II study of carboplatin, irinotecan and bevacizumab for bevacizumab naïve, recurrent glioblastoma  
  Reardon, D.A., Desjardins, A., Peters, K.B., Gururangan, S., Sampson, J.H., McLendon, R.E., Herndon, J.E. II, Bulusu, A., Threatt, S., Friedman, A.H., Vredenburgh, J.J..., J Neurooncol, 1/1/2012
• Editorial: Avastin: More questions than answers  
  Desjardins, A., Sampson, J.H., J Neurosurg, 1/1/2012
• Editorial: Clinical data simplified  
  Sampson, J.H., Herndon, J.E., McLendon, R.E., Hasselblad, V., Asher, A.L., McGirt, M.J., Petereson, E.D., J Neurosurg, 1/1/2012
• Join now to see all

Books/Book Chapters

• Glioma: Symptoms, Diagnosis and Treatment Options. 
  Chapter: Current immunotherapeutic targets in gliomas. 
  Chandramohan, V., Mitchell, D.A., Gromeier, M., Sampson, J.H., and Bigner, D.D.Editors: Vrionis, F.D., Wiranowska, M.Nova Science Publishers, Inc.2013
• Drug Delivery to the Central Nervous System. 
  Chapter: Convection-enhanced drug delivery to the brain. 
  Page 893 - 2336Ding, D., Kanaly, C.W., Brady, M.L., Mittermeyer, S., Raghavan, R., Sampson, J.H.Editors: Jain K.Springer, New York, NY2010
• Neurosurgical Operative Atlas, Functional Neurosurgery. 
  Chapter: Microvascular decompression of the facial nerve for hemifacial spasm. 
  Sampson, J.H., Ellis, M.J., Grossi, P.M., Fukushima, T.Editors: Starr, P., Barbaro N., and Larson, L..Thieme, New York, NYEdition 2nd,2009
• Russell and Rubinstein's Pathology of Tumors of the Nervous System. 
  Chapter: Cellular and Humoral Immunity of Brain Tumors. 
  Page 167 - 230Bigner, D., Sampson J.H.Editors: Bigner, D.D., McLendon, R.E., and Bruner, J.M..Oxford University Press, New York, NYEdition 7th,2006
• The Textbook of Neuro-Oncology. 
  Chapter: Brain metastases for malignant melanoma. 
  Page 430 - 438Sampson, J.H., Shafman, T.D., Carter, Jr., J.H., Friedman, A.H., Seigler, H.F.Editors: Berger, M., and Black, P.M..Elsevier, Philadelphia, PA2005
• Modern Neurosurgery: Clinical Translation of Neuroscience Advances. 
  Chapter: Novel Therapeutic Approaches for High-Grade Gliomas. 
  Page 159 - 184New, K., Adamson, D., Selznick, L., and Sampson, J.H.Editors: Turner, D.A..CRC Press, New York, NY2004
• Glioblastoma Multiforme. 
  Chapter: Adoptive immunotherapy for malignant glioma. 
  Page 206 - 225Mitchell, D.A., Fecci, P.E., Sampson J.H.Editors: Markert, J., DeVita, V., Hellman, S., and Rosenberg, S..Jones and Bartlett Publishers, Sudbury, MA2004
• Brain Tumors. 
  Chapter: Immunotherapy of Central Nervous System Tumors. 
  Page 323 - 342Heimberger, A., Reardon, D., Bigner, D., Sampson, J.H.Editors: Ali-Osman, F..Humana Press, Totowa, NJ2004
• Cancer Handbook. 
  Chapter: Models for CNS malignancies. 
  Page 1123 - 1138Crotty, L.E., Sampson, J.H., Archer, G.E., and Bigner, D.D.Editors: Alison, M.R..Nature Publishing Group, London2002
• Neurosurgery. The Scientific Basis of Clinical Practice. 
  Chapter: The use of experimental models in neurooncological research. 
  Page 596 - 607Sampson, J.H., Archer, G.E., and Bigner, D.D.Editors: Crockard, A., Hayward, R., and Hoff, J..Blackwell Scientific Publications, Oxford, United Kingdom2001
• Brain Tumor Immunotherapy. 
  Chapter: Biological principles of brain tumor immunotherapy. 
  Page 101 - 130Heimberger, A.B., Bigner, D.D., and Sampson, J.H.Editors: Liau, L.M., Becker, D.P., Cloughesy, T.F., and Bigner, D.D..Humana Press, Totowa, NJ2001
• Operative Neurosurgery. 
  Chapter: Surgery for Idiopathic Vagoglossopharyngeal neuralgia. 
  Page 1635 - 1646Sampson, J.H. and Wilkins, R.H.Editors: Kaye, A.H., and Black, P.McL..Churchill Livingstone, London2000
• Gene Transfer and Therapy for Neurological Disease. 
  Chapter: Cytokine-based gene therapy for brain tumors. 
  Page 251 - 304Sampson, J.H., Bigner, D.D., and Dranoff, G.Editors: Chiocca, E.A., and Breakefield, X.O..Humana Press, Totowa, NJ1998
• Russell and Rubinstein's Pathology of Tumors of the Nervous System. 
  Chapter: Experimental tumors and the evaluation of neurocarcinogens. 
  Page 167 - 230Sampson, J.H., and Bigner, D.D.Editors: Bigner, D.D., McLendon, R.E., and Bruner, J.M..Arnold, LondonEdition 6th,1998
• Neurological Surgery: A Comprehensive Reference Guide to the Diagnosis and Management of Neurosurgical Problems. 
  Chapter: Dorsal root entry zone lesions for pain relief. 
  Page 3452 - 3462Nashold, B.S., Jr., Friedman, A.H., Sampson, J.H., Nashold, J.R.B., El-Naggar, A.O.Editors: Youmans, J.R..W.B. Saunders, Philadelphia, PA1996
• The DREZ Operation. 
  Chapter: DREZ lesions for intractable pain after trauma to the conus medullaris and cauda equina. 
  Page 147 - 158Sampson, J.H.Editors: Nashold, B.S., Jr., Pearlstein, R., Friedman, A.H., and Ovelmen Levitt, J..American Association of Neurological Surgeons, Park Ridge, IL1996
• Neurosurgery. 
  Chapter: Dorsal root entry zone lesions for pain relief. 
  Page 4035 - 4046Nashold, B.S., Jr., Sampson, J.H., Nashold, J.R.B., Higgins, A.C., and Blumenkopf, B.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Lumbar spondylolisthesis. 
  Page 3851 - 3858Sampson, J.H., and Wilkins, R.H.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Paragangliomas of the carotid and temporal bodies. 
  Page 1559 - 1571Sampson, J.H., and Wilkins, R.H.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Neurofibromatosis and other phakomatoses. 
  Page 673 - 685Sampson, J.H., and Martuza, R.L.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Genetic factors in brain tumors. 
  Page 665 - 671Sampson, J.H., and Martuza, R.L.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Conn's Current Therapy. 
  Chapter: Acute head injuries in children. 
  Page 901 - 906Oakes, W.J., and Sampson, J.H.Editors: Rakel, R.E..W.B. Saunders, Philadelphia, PA1992
• Basic References in Neurosurgery. 
  Wilkins, R.H., and Sampson, J.H.American Association of Neurological Surgeons, Park Ridge, IL1992
• Basic References in Neurosurgery. 
  Wilkins, R.H., and Sampson, J.H.American Association of Neurological Surgeons, Park Ridge, IL1992
• Join now to see all

Abstracts/Posters

• Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.
  Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K.J., Vredenburgh, J.J., Peters, K., Chang, Z., Herndon, J.E., Desjardins, A., Reardon, D.A., Kirkpatrick, J., J Clin Oncol, 1/1/2011
• Concurrent Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study.
  Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K., Duffy, E., Vredenburgh, J.J., Peters, K.B., Chang, Zheng, Desjardins, A., Kirkpatrick, J.P., ASTRO, Int J Radiat Oncol Biol Phys, 1/1/2011
• Dendritic cell vaccines targeting cytomegalovirus in glioblastoma.
  Mitchell, D.A., Archer, G.E., Friedman, H.S., Herndon, J.E., Bigner, D.D., Sampson, J.H., 16th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2011
• Cytomegalovirus-specific immune deficits in patients with GBM.
  Johnson, L.A., Archer, G.E., Nair, S.K., Schmittling, R., Reap, E., Sampson, J.H., Mitchell, D.A., 16th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2011
• Poor Coverage as a Possible Explanation for the Low Efficacy Results with CED: Simulation Analysis of Patients from the PRECISE Study.
  Sampson, J.H., Pedain, C., Wembacher-Schroder, Rodriguez-Ponce, I., Westphal, M., Kunwar, S., Vogelbaum, M.A., Raghavan, R., Brady, M., Friedman, A.H., Friedman, H.S.,..., J Neurosurg, 5/1/2009
• Interim data for ACT III - phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).
  Lai, R., Recht, L.D., Reardon, D.A., Paleologos, N., Groves, M.D., Rosenfeld, M.R., Meech, S., Davis, T.A., Pavlov, D., Sampson, J.H., 46th Annual Meeting, American Society of Clinical Oncology, J Clin Oncol, 1/1/2009
• Humoral and cell-mediated immune responses to EGFRvIII-targeted vaccine (CDX-110) are enhanced with continuous temozolomide in patients with GBM.
  Archer, G.A., Heimberger, A., Pelloski, C., Hussain, S., Sun, W., Suki, D., Hess, K., Shi, W., Aldape, K., Gilbert, M., Sawaya, R., Schmittling, B., Archer, G., Herndo..., Proc Am Assoc Cancer Res, 4/1/2008
• Temozolomide enhances efficacy of EGFRvIII vaccine (CDX-110) in patients with newly-diagnosed GBM.
  Sampson, J.H. for the EGFRvIII Vaccine Group, J Neurosurg, 4/1/2008
• A phase I/II clinical trial evaluating RNA-loaded dendritic cells targeting human cytomegalovirus in patients with newly-diagnosed GBM.
  Mitchell, D.A., Archer, G.E., McGehee-Norman, S., Perry, B.A., Lally-Goss, D., Schmittling, R., Bigner, D.D., Friedman, A.H., Friedman, H.S., Reardon, D.A., Vredenbur..., J Neurosurg, 4/1/2008
• A curious history of the pineal gland in western mysticism and the occult.
  Gump, W.C., Whitlatch, L.W., Sampson, J.H., J Neurosurg, 4/1/2008
• Efficacy and immunologic effects of RNA-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma.
  Mitchell, D.A., Archer, G.E., Bigner, D.D., Desjardins, A., Friedman, A.H., Friedman, H.S., Lally-Goss, D., Herndon, II, J.E., McGehee, S., McLendon, R.E., Perry, B., ..., Proc Am Assoc Cancer Res, 1/1/2008
• Efficacy of a phase II vaccine targeting cytomegalovirus antigens in newly-diagnosed GBM.
  Mitchell, D.A., Archer, G.E., Bigner, D.D., Friedman, H.S., Lally-Goss, D., Herndon, J.E., McGehee, S., McLendon, R., Reardon, D.A., Sampson, J.H., J Clin Oncol, 1/1/2008
• A genomic approach to define important and targetable molecular pathways in brain metastasis arising from solid tumors.
  Anders, C.K., Hsu, D., Acharya, C., McLendon, R., Sampson, J.H., Vredenburgh, J., Satterfield, D., Spector, N., Potti, A., Blackwell, K.L., J Clin Oncol, 1/1/2008
• Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.
  Sampson, J. H., Archer, G. E., Bigner, D. D., Davis, T., Friedman, H. S., Keler, T., Mitchell, D. A., Reardon, D.A., Sawaya, R., Heimberger, A.B., J Clin Oncol, 1/1/2008
• Stereotactic Body Radiosurgery of the Spine: The Duke Experience.
  Nelson, J.W., Yoo, D.S., Sampson, J.H., Isaacs, R.E., Larrier, N.A., Marks, L.B., Yin, F.F., Wu, Q.J., Wang, Z., Kirkpatrick, J.P., 50th Annual ASTRO Meeting, Int J Rad Oncol Biol Phys, 1/1/2008
• A phase II trial of sorafenib (nexavar) and protracted temozolomide for patients with recurrent glioblastoma.
  Reardon, D.A., Desjardins, A., Vredenburgh, J., Friedman, A.H., Sampson, J.H., Rich, J.N., Friedman, H.A., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• A phase I trial of dasatinib (sprycel) and erlotinib (tarceva) for patients with recurrent malignant glioma.
  Reardon, D.A., Desjardins, A., Vredenburgh, J., Friedman, A.H., Sampson, J.H., Gururangan, S., Rich, J.N., Friedman, H.A., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Surgical resection of malignant glioma in adults less than 30 years old.
  Parker, S., Grossi, P., Sampson, J.H., Friedman, A.H., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Evaluation of dose distribution in pre-operative versus post-operative stereotactic radiosurgery of single brain metastases.
  Aliabadi, H., You, D., Herndon, J.A., Sampson, J.H., Kirkpatrick, J., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Efficacy and immunologic effects of rna-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma.
  Mitchell, D.A., Archer, G.E., Bigner, D., Friedman, H.A., Lally-Goss, D., Perry, B.A., Herndon, J.A., McGehee, S., McClendon, R., Reardon, D., Sampson, J.H., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• The positive influence of temozolomide on the humoral and cell mediated (dth) responses to the EGFRvIII-targeted vaccine (cdx-110) in patients with gbm.
  Archer, G.E., Heimberger, A., Bigner, D., Davis, T., Friedman, H., Friedman, A., Keler, T, Mitchell, D., Reardon, D., Sawaya, R., Vredenburgh, J., Young, A., Rich, J.,..., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Dosimetric and radiobiological impact of a high-definition micromultileaf collimator on radiosurgery of vestibular schwannomas.
  Meyer, J., Wu, Q.J., Sampson, J.H., Yin, F., Tucci, D., David, B., Zhiheng, W., Kirkpatrick, J., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Surgical resection of malignant gliomas in elderly patients older than 70 years of age.
  Grossi, P., Parker, S., Sampson, J.H., Friedman, A.H., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Effect of daclizumab on TReg counts and EGFRvIII-specific immune responses in GBM.
  Sampson, J.H., Archer, G.E., Bigner, D.D., Schmittling, R.J., Herndon, J.E., Davis, T., Friedman, H.S., Keler, T., Reardon, D.A., Mitchell, D.A., 45th Annual Meeting, American Society of Clinical Oncology, J Clin Oncol, 1/1/2008
• EGFRvIII vaccine (CDX-110) alone and with simultaneous temozolomide in patients with newly diagnosed, resected, EGFRVIII positive GBM.
  Heimberger, A., Davis, T., Keler, T., Vitale, L., Sampson, J.H., J Immunother, 1/1/2007
• Join now to see all

Lectures

• Chimeric Antigen Receptor (CAR) and Adoptive Cell Transfer 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Novel role for enhancing immunotherapy against pediatric brain tumors using hematopoietic stem cells. 
  San Francisco, CA - 11/21/2013
• Developmentally regulated antigens for immunologic targeting of medulloblastoma subtypes. 
  San Francisco, CA - 11/21/2013
• RNA nanoparticle vaccines re-direct host-immunity against intracranial malignancies. 
  San Francisco, CA - 11/21/2013
• Early results of a randomized trial of margin expansion in stereotactic radiosurgery for brain metastases. 
  Atlanta, GA - 9/22/2013
• Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma. 
  Chicago, IL - 5/31/2013
• Phase II Trial for Patients with Newly Diagnosed Glioblastoma (GBM) Treated with Gliadel Followed by Concurrent Radiation Therapy (RT), Temozolomide (TMZ) and Bevacizu... 
  Chicago, IL - 5/31/2013
• A Phase I/II study of adoptive T-cell therapy (ALT) and DC vaccination (DCV) during recovery from myeloablative chemotherapy and hematopoietic stem cell transplantatio... 
  Fort Lauderdale, FL - 5/16/2013
• A Phase I/II study of adoptive T-cell therapy (ALT) and DC vaccination (DCV) during recovery from myeloablative chemotherapy and hematopoietic stem cell transplantatio... 
  Fort Lauderdale, FL - 5/16/2013
• Engineering RNA nanoparticle vaccines to target malignant pediatric brain tumors. 
  Miami, FL - 4/24/2013
• Neurokinin-1 Receptor: A potential target to inhibit pediatric glioblastomas. 
  Washington, DC - 11/15/2012
• RNA Nanoparticle vaccines targeting pediatric and adult brain tumors. 
  Washington, DC - 11/15/2012
• Assessment of intratumoral Tregs and clinical outcomes in primary and recurrent GBM. 
  Washington, DC - 11/15/2012
• Myeloablative temozolomide increases antigen-specific CD8+ T-cell vaccine responses and is required for efficacious immunotherapy again intracerebral tumors. 
  Washington, DC - 11/15/2012
• Intravenous treatment with an EGFRvIII-targeted bispecific antibody successfully treats well-established brain tumors. 
  Washington, DC - 11/15/2012
• Development of immunocompetent syngeneic models of medulloblastoma for evaluation of immunotherapy. 
  Washington, DC - 11/15/2012
• Feasibility of amplified CD133(+) brain tumor stem cell RNA-pulsed dendritic cells for the treatment of patients with recurrent glioblastoma. 
  Washington, DC - 11/15/2012
• Targeting Cytomegalovirus (CMV) antigens for GBM immunotherapy. 
  Washington, DC - 11/15/2012
• Role of hematopoietic stem cells in enhancing the anti-tumor efficacy of adoptive cellular therapy. 
  Washington, DC - 11/15/2012
• Ex vivo generating central memory-like anti-tumor T cells to treat malignant brain tumors. 
  Washington, DC - 11/15/2012
• Adoptive cellular therapy during recovery from treatment-induced lymphopenia in pediatric patients with recurrent medulloblastoma and PNETs. 
  Washington, DC - 11/15/2012
• Phase I trial of gliadel plus temodar. 
  Chicago, IL - 11/9/2012
• Unarmed, tumor-specific antibody effectively treats brain tumors. 
  Chicago, IL - 11/9/2012
• Impact of concurrent and adjuvant bevacizumab on the risk of radiation necrosis following radiosurgery for recurrent glioma. 
  Boston, MA - 10/28/2011
• Joe Doupe Memorial Lecture. 
  Winnipeg, Manitoba, Canada - 9/8/2011
• Join now to see all

Other

• Novel Therapies in the Management of Malignant Brain Tumors: Bevacizumab and Surgery. 
  Chang, S., Sampson, J.H., Aghi, M., Theodosopoulos, P.V., CNS Neurosurger Webinars, Controversies in Neuro-Oncology: An Academic- Community Forum
  1/12/2010
• Cell-mediated immunotherapy of brain tumors. 
  Sampson, J.H., Doctoral Thesis Defense, Duke University
  12/5/1996